Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1992 Jan;60(1):90–94. doi: 10.1128/iai.60.1.90-94.1992

Comparison of irradiated-cercaria schistosome vaccine models that use 15- and 50-kilorad doses: the 15-kilorad dose gives greater protection, smaller liver sizes, and higher gamma interferon levels after challenge.

S R Reynolds 1, D A Harn 1
PMCID: PMC257507  PMID: 1729200

Abstract

The protection and immune response to infection caused by the parasite Schistosoma mansoni were studied by comparison of two murine irradiated-vaccine models. Mice were exposed from 1 to 4 times to infective-stage cercariae attenuated with either a moderate dose (15 kilorads) or a high dose (50 kilorads) of radiation. Seven weeks after challenge infection, the mice were assessed for resistance, liver size, and lymphokine responses to parasite antigens. Both vaccine models showed high levels of protection, but the moderate-dose model proved superior in that mice in those groups achieved higher levels of resistance in fewer exposures. Additionally, the mice exposed three times and four times to moderately irradiated cercariae all had significantly lower liver weights independent of worm burden. Assessment of lymphokine production by the spleen cells at the time of perfusion showed that gamma interferon was the only lymphokine of those measured that was differentially produced in the two models and correlated with a decrease in size of in vitro granulomas. The findings suggest that a selected vaccine regimen may lead to greater resistance and decreased liver pathology, the latter of which appears to be mediated by induction of gamma interferon.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bentley A. G., Phillips S. M., Kaner R. J., Theodorides V. J., Linette G. P., Doughty B. L. In vitro delayed hypersensitivity granuloma formation: development of an antigen-coated bead model. J Immunol. 1985 Jun;134(6):4163–4169. [PubMed] [Google Scholar]
  2. Bickle Q. D., Dobinson T., James E. R. The effects of gamma-irradiation on migration and survival of Schistosoma mansoni schistosomula in mice. Parasitology. 1979 Oct;79(2):223–230. doi: 10.1017/s0031182000053300. [DOI] [PubMed] [Google Scholar]
  3. Bickle Q. D., Taylor M. G., Doenhoff M. J., Nelson G. S. Immunization of mice with gamma-irradiated intramuscularly injected schistosomula of Schistosoma mansoni. Parasitology. 1979 Oct;79(2):209–222. doi: 10.1017/s0031182000053294. [DOI] [PubMed] [Google Scholar]
  4. Cheever A. W. Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bull World Health Organ. 1968;39(2):328–331. [PMC free article] [PubMed] [Google Scholar]
  5. Damian R. T., Roberts M. L., Powell M. R., Clark J. D., Lewis F. A., Stirewalt M. A. Schistosoma mansoni egg granuloma size reduction in challenged baboons after vaccination with irradiated cryopreserved schistosomula. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3552–3556. doi: 10.1073/pnas.81.11.3552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dean D. A. Schistosoma and related genera: acquired resistance in mice. Exp Parasitol. 1983 Feb;55(1):1–104. doi: 10.1016/0014-4894(83)90002-4. [DOI] [PubMed] [Google Scholar]
  7. Doughty B. L., Goes A. M., Parra J. C., Rocha R. S., Katz N., Colley D. G., Gazzinelli G. Granulomatous hypersensitivity to Schistosoma mansoni egg antigens in human schistosomiasis. I. Granuloma formation and modulation around polyacrylamide antigen-conjugated beads. Mem Inst Oswaldo Cruz. 1987;82 (Suppl 4):47–54. doi: 10.1590/s0074-02761987000800009. [DOI] [PubMed] [Google Scholar]
  8. Duvall R. H., DeWitt W. B. An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg. 1967 Jul;16(4):483–486. doi: 10.4269/ajtmh.1967.16.483. [DOI] [PubMed] [Google Scholar]
  9. Harn D. A., Danko K., Quinn J. J., Stadecker M. J. Schistosoma mansoni: the host immune response to egg antigens. I. Partial characterization of cellular and humoral responses to pI fractions of soluble egg antigens. J Immunol. 1989 Mar 15;142(6):2061–2066. [PubMed] [Google Scholar]
  10. Harn D. A., Mitsuyama M., David J. R. Schistosoma mansoni. Anti-egg monoclonal antibodies protect against cercarial challenge in vivo. J Exp Med. 1984 May 1;159(5):1371–1387. doi: 10.1084/jem.159.5.1371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hsü S. Y., Hsü H. F., Burmeister L. F. Schistosoma mansoni: vaccination of mice with highly x-irradiated cercariae. Exp Parasitol. 1981 Aug;52(1):91–104. doi: 10.1016/0014-4894(81)90065-5. [DOI] [PubMed] [Google Scholar]
  12. James S. L., Cook K. W., Lazdins J. K. Activation of human monocyte-derived macrophages to kill schistosomula of Schistosoma mansoni in vitro. J Immunol. 1990 Oct 15;145(8):2686–2690. [PubMed] [Google Scholar]
  13. Jwo J., LoVerde P. T. Large-scale production of monoclonal antibodies. Biotechniques. 1988 Sep;6(8):734–738. [PubMed] [Google Scholar]
  14. Menson E. N., Wilson R. A. Lung-phase immunity to Schistosoma mansoni. Flow cytometric analysis of macrophage activation states in vaccinated mice. J Immunol. 1989 Oct 1;143(7):2342–2348. [PubMed] [Google Scholar]
  15. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986 Apr 1;136(7):2348–2357. [PubMed] [Google Scholar]
  16. Pearce E. J., Caspar P., Grzych J. M., Lewis F. A., Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med. 1991 Jan 1;173(1):159–166. doi: 10.1084/jem.173.1.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Reynolds S. R., Kunkel S. L., Thomas D. W., Higashi G. I. T cell clones for antigen selection and lymphokine production in murine Schistosomiasis mansoni. J Immunol. 1990 Apr 1;144(7):2757–2762. [PubMed] [Google Scholar]
  18. Schumacher J. H., O'Garra A., Shrader B., van Kimmenade A., Bond M. W., Mosmann T. R., Coffman R. L. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. J Immunol. 1988 Sep 1;141(5):1576–1581. [PubMed] [Google Scholar]
  19. Sher A., Coffman R. L., Hieny S., Cheever A. W. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J Immunol. 1990 Dec 1;145(11):3911–3916. [PubMed] [Google Scholar]
  20. Sher A., Hieny S., James S. L., Asofsky R. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. II. Analysis of immunity in hosts deficient in T lymphocytes, B lymphocytes, or complement. J Immunol. 1982 Apr;128(4):1880–1884. [PubMed] [Google Scholar]
  21. Smithers S. R., Terry R. J. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology. 1965 Nov;55(4):695–700. doi: 10.1017/s0031182000086248. [DOI] [PubMed] [Google Scholar]
  22. WARREN K. S. The etiology of hepato-splenic Schistosomiasis mansoni in mice. Am J Trop Med Hyg. 1961 Nov;10:870–876. doi: 10.4269/ajtmh.1961.10.870. [DOI] [PubMed] [Google Scholar]
  23. Warren K. S., Domingo E. O., Cowan R. B. Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol. 1967 Nov;51(5):735–756. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES